Search | Result

ID 1283
Class Mammalia
Species Homo sapiens
Tissue Blood
Sample Blood
Disease type Covid-19
Cell type CD8 T cells
Cell type (subtype) Cytotoxic
Cell marker NKG7, GZMA, GZMB, CCR7, PRF1, LEF1, CCL4, SELL, TCF7, IFNG, CST7, CCL3
Frequency
PubMed ID 33171100
Journal Cell
SCI IF 38.637
Evidence For CD8+ T cells na_ve (TCF7, LEF1, SELL, CCR7), cytotoxic (NKG7, CCL4, CST7, PRF1, GZMA, GZMB, IFNG, CCL3), exhaustion (PDCD1, TIGIT, LAG3, HAVCR2, CTLA4), and proliferation (MKI67, TYMS) signature scores were calculated. For CD4+ T cells na_ve (TCF7, LEF1, SELL, CCR7), cytotoxic (GZMB, PRF1, GNLY), exhaustion (PDCD1, TIGIT, LAG3, HAVCR2, CTLA4), and proliferation(MKI67, TYMS) signature scores were calculated;We observed significant activation in na_ve B cells (downregulation of FCER2 and upregulation ofSLAMF7) and expansion of antibody-secreting cells (ASCs) in moderate and severe samples compared to healthy and mild ones (Figures 4A-C). A distinct memory B cell population that has high expression in ITGAX and FCRL5 (Figure 4A), resembling a tissue-like memory B cell phenotype
Title Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Authors Su Y et al.
Date 2020.11
Data available NA